Table 2.
Prior knowledge of BDNF and mortality association mediated by cortisol level among all subjects and stratified by 75th quartile of age.
| All subjects (N = 185) | Age ≤ 48 years (N = 139) | Age >48 years (N = 46) | ||||
|---|---|---|---|---|---|---|
| Pathwaya | β (SE) | P-value | β (SE) | P-value | β (SE) | P-value |
| BDNF to Cortisol (Logistic)b | 1.35 (0.48) | 0.005 | 1.94 (0.61) | 0.001 | 0.30 (0.75) | 0.694 |
| Cortisol to mortality (Cox) | 1.13 (0.40) | 0.005 | 1.00 (0.56) | 0.095 | 1.27 (0.57) | 0.026 |
| BDNF to mortality-Total Effect (Cox) | 0.65 (0.30) | 0.033 | 1.03 (0.42) | 0.015 | 0.30 (0.41) | 0.457 |
| BDNF to mortality-Direct Effect (Cox)c | 0.47 (0.38) | 0.217 | 0.54 (0.65) | 0.407 | 0.48 (0.49) | 0.324 |
All pathways adjusted for 75th percentile age (at 48 year old).
Weekly average CSF BDNF in ng/mL (≥75th percentile, <75th percentile); CSF cortisol using trajectory analysis grouping (low vs. high).
Also adjusted for cortisol trajectory grouping (low vs. high).
Bolded p-values indicate statistical significance.